Menu
Home
Herausgeber
Kategorien
Trend
Posteingang
Konto erstellen
Anmelden
Nederlands
English
Learn why EssilorLuxottica has an R&D centre in Singapore
Edb.gov.sg
Abonnieren
0
Klicken Sie hier, um Edb.gov.sg zu abonnieren
Laden...
1 Monat vor
Html
Text
More on Pall’s new US$150m facility, Singapore’s vibrant MedTech scene and sustainability updates
View in browser here
.
SG Industry Moves:
US-headquartered Pall Corporation opens US$150m manufacturing facility in Singapore to serve growing demand from semiconductor customers
Read more
Sustainability updates: Clean energy gets a boost with new hydrogen-ready power plants and floating solar farm
See all updates
The pursuit of AI innovation: Insights from Accenture Singapore’s Managing Director Mark Tham
Get insights
1 in 10 contact lenses used globally made here: Singapore’s thriving MedTech industry and its impact
Learn more
Access essential resources to accelerate growth and strengthen your supply chain in Southeast Asia
Access now
3-4 Oct: Join us at Singapore Supply Chain Connect 2024! Get exclusive insights from Gartner, McKinsey, S&P Global, DHL and more, as we discuss forward-looking strategies to de-risk your supply chain network in SEA
Register now
Brought to you by
Singapore Economic Development Board
250 North Bridge Road
#28-00 Raffles City Tower
Singapore 179101
Connect with EDB
:
Scan QR code to connect on WeChat
You received this email because you signed up for regular updates on Asian business insights and news.
To contact us or unsubscribe, please use the links below.
Contact us
|
Update preferences
|
Unsubscribe
|
Privacy policy
|
Terms of use
Teilen auf
Laden...
Weitere Newsletter von
Edb.gov.sg
Pfizer invests S$1b in Singapore to boost API manufacturing
Edb.gov.sg
Vor 11 Tagen
Learn why EssilorLuxottica has an R&D centre in Singapore
Edb.gov.sg
1 Monat vor
Pharma giant AstraZeneca invests US$1.5b in Singapore manufacturing facility
Edb.gov.sg
2 Monate vor
Weitere Newsletter von Edb.gov.sg
Laden...
Verwandte Newsletter
[[subject]]
[[publisher.name]]
[[date]]
© 2024
Allgemeine Geschäftsbedingungen
Privatleben
Schließen
Home
Herausgeber
Kategorien
Trend
Posteingang
Konto erstellen
Anmelden
© 2024
Allgemeine Geschäftsbedingungen
Privatleben
Nederlands
English